These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8628015)

  • 1. Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3.
    Caligo MA; Cipollini G; Petrini M; Valentini P; Bevilacqua G
    Leuk Res; 1996 Feb; 20(2):161-7. PubMed ID: 8628015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
    Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.
    Valentijn LJ; Koppen A; van Asperen R; Root HA; Haneveld F; Versteeg R
    Cancer Res; 2005 Apr; 65(8):3136-45. PubMed ID: 15833843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors.
    Schmidt B; Ackermann R; Hartmann M; Strohmeyer T
    J Urol; 1997 Nov; 158(5):2000-5. PubMed ID: 9334657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis.
    Postel EH; Berberich SJ; Flint SJ; Ferrone CA
    Science; 1993 Jul; 261(5120):478-80. PubMed ID: 8392752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development.
    Wallet V; Mutzel R; Troll H; Barzu O; Wurster B; Veron M; Lacombe ML
    J Natl Cancer Inst; 1990 Jul; 82(14):1199-202. PubMed ID: 2163458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.
    Seifert M; Seib T; Engel M; Dooley S; Welter C
    Biochem Biophys Res Commun; 1995 Oct; 215(3):910-4. PubMed ID: 7488060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions.
    Postel EH; Ferrone CA
    J Biol Chem; 1994 Mar; 269(12):8627-30. PubMed ID: 8132589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription effect of nm23-M2/NDP kinase on c-myc oncogene.
    Lee IH; Chang SI; Okada K; Baba H; Shiku H
    Mol Cells; 1997 Oct; 7(5):589-93. PubMed ID: 9387143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.
    Yamashiro S; Urano T; Shiku H; Furukawa K
    Oncogene; 1994 Sep; 9(9):2461-8. PubMed ID: 8058309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell differentiation and down regulation of nm23 gene expression in HL-60 cells induced by 1,25 dihydroxyvitamin D3].
    Zhu N; Lu Q; Zhou Y
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):639-41. PubMed ID: 16200712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a second human nm23 gene, nm23-H2.
    Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS
    Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NM23 gene expression correlates with cell growth rate and S-phase.
    Caligo MA; Cipollini G; Fiore L; Calvo S; Basolo F; Collecchi P; Ciardiello F; Pepe S; Petrini M; Bevilacqua G
    Int J Cancer; 1995 Mar; 60(6):837-42. PubMed ID: 7896455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
    Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
    Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes.
    Okada K; Urano T; Baba H; Furukawa K; Furukawa K; Shiku H
    Oncogene; 1996 Nov; 13(9):1937-43. PubMed ID: 8934540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NM23/Nucleoside diphosphate kinase as a transcriptional activator of c-myc.
    Postel EH
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():233-52. PubMed ID: 9053293
    [No Abstract]   [Full Text] [Related]  

  • 19. Transactivation potential of the C-terminus of human Nm23-H1.
    Chae SK; Lee NS; Lee KJ; Kim E
    FEBS Lett; 1998 Feb; 423(2):235-8. PubMed ID: 9512364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
    Berberich SJ; Postel EH
    Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.